Future Market Insights.png
Peptide Therapeutics Market Expanding at an Impressive CAGR of 11% over the period of 2022 to 2025 | Future Market Insights, Inc.
September 06, 2022 07:30 ET | Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, Sept. 06, 2022 (GLOBE NEWSWIRE) -- The global peptide therapeutics market is projected to reach a valuation of US$ 47 Bn in 2025, with sales growing at a prolific CAGR of 11% from 2022...
logo-alt.png
Peptide Therapeutics Market is estimated to be US$ 66.18 billion by 2030 with a CAGR of 6.10% during the forecast period - By PMI
July 04, 2022 09:43 ET | PMI
Covina, July 04, 2022 (GLOBE NEWSWIRE) -- The joining of two or more amino acid monomers via amide bonds forms peptides. The size of a peptide is what separates it from a protein. Peptides are...
MBX Logos FINAL FULL.jpg
MBX Biosciences Appoints Richard B. Bartram as Chief Financial Officer
April 11, 2022 07:30 ET | MBX Biosciences, Inc.
CARMEL, Ind., April 11, 2022 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing peptide therapeutics with a focus on the treatment of endocrine...
Roots-Analysis-Logo.png
The peptide therapeutics contract API manufacturing market is anticipated to grow at an annualized rate of 13.6%, claims Roots Analysis
April 07, 2022 09:30 ET | Roots Analysis
London, April 07, 2022 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Peptide Therapeutics: Contract API Manufacturing Market (2nd Edition), 2022-2035” report to its list of...
MBX Logos FINAL FULL.jpg
MBX Biosciences Appoints Ora Hirsch Pescovitz, M.D., to Board of Directors
April 05, 2022 08:00 ET | MBX Biosciences, Inc.
CARMEL, Ind., April 05, 2022 (GLOBE NEWSWIRE) -- MBX Biosciences, Inc., a clinical stage biopharmaceutical company developing peptide therapeutics with a focus on the treatment of endocrine...
Roots-Analysis-Logo.png
The peptide therapeutics market is projected to be worth around USD 41.7 Billion in 2030, claims Roots Analysis
September 09, 2021 08:36 ET | Roots Analysis
London, Sept. 09, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of the “Peptide Therapeutics Market, 2021 – 2030” report to its list of offerings. Characterized by a rapidly...
TIP_link_300x300.jpg
Peptide Therapeutics Market to Outstrip $50,003.15 Million by 2027 Growing Sturdy at 9.2% CAGR - COVID-19 Impact and Global Analysis by TheInsightPartners.com
June 09, 2021 11:13 ET | The Insight Partners
Pune, India., June 09, 2021 (GLOBE NEWSWIRE) -- Peptide Therapeutics Market: Key InsightsAccording to our new research study on “Peptide Therapeutics Market to 2027 – Global Analysis and Forecast –...
Peptomyc Board of Directors appoints Giacomo Di Nepi as Chairman of the Board
January 06, 2021 18:00 ET | Peptomyc S.L.
BARCELONA, Spain, Jan. 07, 2021 (GLOBE NEWSWIRE) -- Peptomyc S.L., a biotech company specialized in the development of protein and peptide therapeutics targeting the Myc oncoprotein for cancer...
logo.jpg
Global Peptide Therapeutics Market Size Growth Forecast Sales Clinical Trials Insight 2026
November 11, 2020 03:36 ET | KuicK Research
DELHI, India, Nov. 11, 2020 (GLOBE NEWSWIRE) -- “Global Peptide Therapeutics Market & Clinical Pipeline Insight 2026” report highlights: Global Peptide Therapeutics Market Opportunity: US$ 65...
Z_ID_ORG_FINAL_w_name_rgb_NEW2.jpg
Zealand Pharma to leverage Intomics bioinformatics platform within peptide drug discovery and development process
June 10, 2020 02:00 ET | Zealand Pharma
Press Release – No. 07 / 2020 Zealand Pharma to leverage Intomics bioinformatics platform within peptide drug discovery and development process The research agreement enhances Zealand Pharma’s...